ライフサイエンスコーパス: Freund's adjuvant

1 n complete Freund's adjuvant (CFA/incomplete Freund's adjuvant).

2 itoneally with sheep IgG (0.2 mg in complete Freund's adjuvant).

3 ture of antigens which characterize Complete Freund's Adjuvant.

4 retinoid-binding protein (IRBP) in complete Freund's adjuvant.

5 All mice were immunized with TAChR in Freund's adjuvant.

6 mAb MK2-23 conjugated to KLH and given with Freund's adjuvant.

7 istration of capsaicin, formalin or complete Freund's adjuvant.

8 DNA or 5gP protein emulsified in ISA 720 or Freund's adjuvant.

9 to be more effective than emulsification in Freund's adjuvant.

10 humans, with immunization of 5gP protein in Freund's adjuvant.

11 sponsive to rechallenge with OVA in complete Freund's adjuvant.

12 nduced by intraplantar injection of complete Freund's adjuvant.

13 o tolerant to challenge with OVA in complete Freund's adjuvant.

14 ith 1 mg of immunogen emulsified in complete Freund's adjuvant.

15 inflammatory stimuli, formalin and complete Freund's adjuvant.

16 e obtained by formulation of the vaccines in Freund's adjuvant.

17 nimals immunized with ovalbumin and complete Freund's adjuvant.

18 eous injections of CM emulsified in complete Freund's adjuvant.

19 animals with recombinant phogrin in complete Freund's adjuvant.

20 h this epitope when administered in complete Freund's adjuvant.

21 d-binding protein (IRBP) mixed with complete Freund's adjuvant.

22 s were immunized with ovalbumin and complete Freund's adjuvant.

23 nant protein consisting of the C terminus in Freund's adjuvant.

24 to that seen in mice immunized with complete Freund's adjuvant.

25 routes and even in the presence of complete Freund's adjuvant.

26 injection of P gamma emulsified in complete Freund's adjuvant.

27 ining the 36 kDa protein (p-36) and complete Freund's adjuvant.

28 inactivated influenza virus formulated with Freund's adjuvant.

29 rons during inflammation induced by complete Freund's adjuvant.

30 with 100 micrograms of rgp120SF2 in complete Freund's adjuvant.

31 of myeloid cells upon injection of complete Freund's adjuvant.

32 ng immunization with OVA protein in complete Freund's adjuvant.

33 nduced by MF59 but not by alum or incomplete Freund's adjuvant.

34 lpha-myosin heavy chain peptide and complete Freund's adjuvant.

35 zation with PLP(139-151) peptide in complete Freund's adjuvant.

36 saccharide, aluminium hydroxide and complete Freund's adjuvant.

37 in either incomplete (IFA) or complete (CFA) Freund's adjuvant.

38 rat hindpaw 2 d after injection of complete Freund's adjuvant.

39 cell was given subcutaneously in incomplete Freund's adjuvant.

40 eliminates all undesired side effects of the Freund's adjuvants.

41 rabbits immunized with 2/6/7- or 2/6-VLPs in Freund's adjuvants.

42 us CpG 1826, 0 of 4 (0%) with CFA/incomplete Freund's adjuvant, 0 of 4 (0%) with CpG 1826 mixed with

43 (HLA-A-like) peptides emulsified in complete Freund's adjuvant 7 d before transplantation (n = 5 to 7

44 nd paw swelling to paw injection of complete Freund's adjuvant, a model of peripheral inflammatory pa

45 intraperitoneal immunization with incomplete Freund's adjuvant, a protocol previously thought to indu

46 a high dose of HEL emulsified in incomplete Freund's adjuvant, a strong splenic proliferative respon

47 Mice immunized with Freund's adjuvant alone have no measurable Ab binding to

48 Freund's adjuvant, whereas controls received Freund's adjuvant alone.

49 pheral nerve injury or injection of Complete Freund's Adjuvant, although they display intact nocicept

50 llowing a subcutaneous injection of complete Freund's adjuvant, an inducer of chronic inflammation.

51 h purified recombinant LppQ-N' formulated in Freund's adjuvant and challenged them with M. mycoides s

52 rived protein extract emulsified in complete Freund's adjuvant and found that these mice developed ca

53 peptide, HPV16 E7, were mixed in incomplete Freund's adjuvant and injected subcutaneously.

54 in control animals immunized with incomplete Freund's adjuvant and injected with cytokines.

55 of sera from immunized mice in the complete Freund's adjuvant and Montanide ISA51 groups and after a

56 ed antigen (MAA) and two adjuvants (complete Freund's adjuvant and purified pertussis toxin).

57 antigen, with or without adjuvant (complete Freund's adjuvant and purified pertussis toxin).

58 e were immunized with cardiac myosin (CM) in Freund's adjuvant and received heterotopic, minor antige

59 211 suppressed allodynia induced by complete Freund's adjuvant and the chemotherapeutic agent paclita

60 d groups of rabbits (n = 7) with each MAP in Freund's adjuvant and then exposed all rabbits to a 200-

61 were primed in vivo with ovalbumin-complete Freund's adjuvant and then restimulated ex vivo.

62 t proteins from NTHi, or saline (control) in Freund's adjuvant and then were challenged by intrabulla

63 by immunization with an emulsion of complete Freund's adjuvant and type II collagen (CII).

64 These two antigens were each emulsified with Freund's adjuvant and used to vaccinate Aotus nancymai m

65 or G9-154 (KTWGQYWQV) peptides in Incomplete Freund's Adjuvant and were tested for the ability to be

66 vaccines, we tested gD2 in alum/MPL, gD2 in Freund's adjuvant, and dl5-29 (a replication-defective H

67 oved for use in humans, was as protective as Freund's Adjuvant, and protective vaccination correlated

68 num hydroxide, calcium phosphate, incomplete Freund's adjuvant, and the oil-in-water emulsion MF59.

69 b12D4 was assessed in the formalin, complete Freund's adjuvant, and visceral pain models.

70 In the complete Freund's adjuvant- and carrageenan-induced thermal hyper

71 After challenge with HEL-complete Freund's adjuvant as adults, immunoglobulin (Ig)G2a isot

72 PBS and Freund's adjuvant or with PPSV23 and Freund's adjuvant at 48 hours after infection (P </= 0.0

73 h, once immediately post- and again 2 h post-Freund's adjuvant at GB 30, at the junction of the later

74 Select CpG ODN were as effective as complete Freund's adjuvant at inducing an antigen-specific antibo

75 Animals were immunized with complete Freund's adjuvant at the tail base.

76 oPn) major outer membrane protein (MOMP) and Freund's adjuvant can protect mice against a genital cha

77 med by an intraplantar injection of complete Freund's adjuvant (CFA) 48 hr earlier (p < 0.001).

78 th antigen, compared favorably with complete Freund's adjuvant (CFA) and alum in eliciting tt specifi

79 culture filtrate antigen (CneF) in complete Freund's adjuvant (CFA) and the other heat-killed Crypto

80 Rodents immunized with complete Freund's adjuvant (CFA) are resistant to subsequent atte

81 pain: (i) intraplantar injection of complete Freund's adjuvant (CFA) as a model of adjuvant- and path

82 NH2-terminal aminoacids of MBP) in complete Freund's adjuvant (CFA) causes paralysis.

83 with Arg(12) mutant ras peptide in complete Freund's adjuvant (CFA) develop T cells within 10 d that

84 clerosis (MS), relies on the use of complete Freund's adjuvant (CFA) emulsions.

85 C harvested from mice injected with complete Freund's adjuvant (CFA) enhanced type-1 cytokine respons

86 th a uveitogenic regimen of IRBP in complete Freund's adjuvant (CFA) exhibited CD25+ regulatory cells

87 ed with a single dose of vaccine in complete Freund's adjuvant (CFA) generated antigen-specific gamma

88 isolated from rats with or without complete Freund's adjuvant (CFA) hindpaw inflammation, in respons

89 obtained from rats with or without complete Freund's adjuvant (CFA) hindpaw inflammation.

90 more efficient than free peptide in complete Freund's adjuvant (CFA) in inducing T cell activation an

91 tory injury induced by injection of complete Freund's adjuvant (CFA) in one hindpaw.

92 inflammatory injury by injection of complete Freund's adjuvant (CFA) in one hindpaw.

93 ation in mice and rats by injecting complete Freund's adjuvant (CFA) in the hindpaw.

94 nduced by intradermal injections of complete Freund's adjuvant (CFA) in the left leg.

95 persistent inflammation induced by complete Freund's adjuvant (CFA) increased GABAergic miniature IP

96 d dose-dependently potently reduced complete Freund's adjuvant (CFA) induced chronic inflammatory pai

97 Y-1797 were demonstrated in a mouse complete Freund's adjuvant (CFA) inflammatory pain model.

98 ng hindlimb inflammation induced by complete Freund's adjuvant (CFA) injections in the hindpaw and hi

99 Complete Freund's Adjuvant (CFA) injections into the hindpaw indu

100 cies were measured hourly following complete Freund's adjuvant (CFA) injections.

101 Injection of complete Freund's adjuvant (CFA) into a hindpaw produced a persis

102 ng this model, induced by injecting complete Freund's adjuvant (CFA) into one hind paw, we systematic

103 induced by subcutaneously injecting complete Freund's adjuvant (CFA) into the hind paws of rats.

104 lammation, induced by injections of complete Freund's adjuvant (CFA) into the hindpaw.

105 nduced by a unilateral injection of complete Freund's adjuvant (CFA) into the masseter muscle under m

106 IP was induced by injection of Complete Freund's Adjuvant (CFA) into the plantar surface of the

107 rats were injected bilaterally with complete Freund's adjuvant (CFA) into the TMJ or served as uninje

108 Immunotherapy with Complete Freund's adjuvant (CFA) is effective in ameliorating aut

109 To this end, the complete Freund's adjuvant (CFA) model of inflammation was used t

110 ced thermal hypersensitivity in the complete Freund's adjuvant (CFA) model of inflammatory pain (1.3-

111 st inflammatory hyperalgesia in the complete Freund's adjuvant (CFA) model.

112 persistent inflammation induced by Complete Freund's adjuvant (CFA) modulates GABA signaling differe

113 ated mechanical hyperalgesia in the complete Freund's adjuvant (CFA) mouse model of inflammatory pain

114 low-pathology BL/6 mice with SEA in complete Freund's adjuvant (CFA) once before, and once again duri

115 hed mechanical allodynia induced by complete Freund's adjuvant (CFA) or by partial sciatic nerve liga

116 on with ovalbumin administered with complete Freund's adjuvant (CFA) or CFA alone.

117 myelin basic protein emulsified in complete Freund's adjuvant (CFA) or passively by the transfer of

118 s the protective response, CneF, in complete Freund's adjuvant (CFA) or the immunogen that induces th

119 rough preinjection with beta-gal in complete Freund's adjuvant (CFA) or through preinjection with sol

120 Hindpaw intraplantar injection of complete Freund's adjuvant (CFA) produced peripheral inflammation

121 in rodents by hindpaw injection of complete Freund's adjuvant (CFA) produces anhedonia and dysregula

122 How strong adjuvants such as complete Freund's adjuvant (CFA) promote T cell priming to protei

123 face adhesin A (PsaA) emulsified in complete Freund's adjuvant (CFA) provides protection against syst

124 -4 weeks on their respective diets, complete Freund's adjuvant (CFA) was injected in one hindpaw to i

125 Seven days after PTX, complete Freund's adjuvant (CFA) was injected into the plantar su

126 used a model of arthritis in which complete Freund's adjuvant (CFA) was injected into the rat ankle

127 Complete Freund's adjuvant (CFA) was injected unilaterally into t

128 Complete Freund's adjuvant (CFA) was used to induce inflammatory

129 usly injection of (1) GA mixed with complete Freund's adjuvant (CFA), (2) CFA alone, or (3) saline.

130 to the epitope peptide delivered in complete Freund's adjuvant (CFA), and IgM production was even gre

131 injection of an inflammatory agent, complete Freund's adjuvant (CFA), into the masseter muscle.

132 inducing liver histologic change as complete Freund's adjuvant (CFA), the standard adjuvant used for

133 g protein1-20 peptide (IRBP1-20) in complete Freund's adjuvant (CFA), with or without a preceding ATR

134 jection of formalin, carrageenan or complete Freund's adjuvant (CFA), without affecting basal pain pe

135 ted in the K/BxN serum-transfer and complete Freund's adjuvant (CFA)-evoked active immunization model

136 In complete Freund's adjuvant (CFA)-induced chronic inflammatory pai

137 f the mTOR signaling pathway during complete Freund's adjuvant (CFA)-induced chronic inflammatory pai

138 nts in DRG neurons dissociated from complete Freund's adjuvant (CFA)-induced inflamed rats.

139 r findings were that 48 h following complete Freund's adjuvant (CFA)-induced inflammation, the propor

140 mined the relative contributions of complete Freund's adjuvant (CFA)-induced inflammatory pain and op

141 ates inflammatory hyperalgesia in a complete Freund's adjuvant (CFA)-induced inflammatory pain rat mo

142 tional deletion of Orai1 attenuates Complete Freund's adjuvant (CFA)-induced pain hypersensitivity in

143 tional deletion of Orai1 attenuates complete Freund's adjuvant (CFA)-induced pain hypersensitivity.

144 We report that complete Freund's adjuvant (CFA)-induced peripheral inflammation

145 PD) mRNA than did the adults during complete Freund's adjuvant (CFA)-induced peripheral inflammation.

146 use formalin assay and also reduced complete Freund's adjuvant (CFA)-induced thermal hyperalgesia and

147 The 3d mutation slightly reduced complete Freund's adjuvant (CFA)-mediated antigen presentation, b

148 ammatory pain, which was induced by complete Freund's adjuvant (CFA).

149 nduced by intraplantar injection of complete Freund's adjuvant (CFA).

150 tein peptide 35-55 (MOG peptide) in complete Freund's adjuvant (CFA).

151 or MOG40-54 peptides emulsified in complete Freund's adjuvant (CFA).

152 n of mechanical allodynia after intraplantar Freund's adjuvant (CFA).

153 tions of pertussis toxin (PTx) plus complete Freund's adjuvant (CFA).

154 mation was induced by injections of complete Freund's adjuvant (CFA).

155 s rats with myelin basic protein in complete Freund's adjuvant (CFA).

156 oduced by intraplantar injection of complete Freund's adjuvant (CFA).

157 ca acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA).

158 by intraplantar (ipl) injection of complete Freund's adjuvant (CFA).

159 ikrein 1b22 (Klk1b22) emulsified in complete Freund's adjuvant (CFA).

160 ion induced by hindpaw injection of complete Freund's adjuvant (CFA): artemin expression increased 10

161 6 d after intraplantar injection of Complete Freund's Adjuvant (CFA)].

162 onferred by yMSP1(19) emulsified in complete Freund's adjuvant (CFA/incomplete Freund's adjuvant).

163 llowing paw inflammation induced by complete Freund's adjuvant (CFA; 1:1 injected s.c. in a 0.01 ml v

164 (8-60 min), carrageenan (3 hr), and complete Freund's adjuvant (CFA; 3 d) into the rat hindpaw as wel

165 ltrate antigen (CneF) emulsified in complete Freund's adjuvant (CneF-CFA).

166 on with schistosome egg antigens in complete Freund's adjuvant, coinfection with the nematodes also r

167 n were noted, for dams immunized with gB and Freund's adjuvant, compared with dams immunized with gB

168 On day 5 after injection of complete Freund's adjuvant containing heat-killed Mycobacterium t

169 rculosis, an essential component of complete Freund's adjuvant, converted CD11b(hi)CD11c(-) monocytes

170 odendrocyte glycoprotein peptide in complete Freund's adjuvant, correlating with milder experimental

171 The vaccines included incomplete Freund's adjuvant, CpG oligodeoxynucleotide (CpG), and t

172 c antibody; only those animals given PYC2 in Freund's adjuvant demonstrated a significant degree of p

173 unized with a P55 fusion protein in complete Freund's adjuvant developed anti-P55 antibodies, detecta

174 x rabbits vaccinated with the MAP peptide in Freund's adjuvant developed high-titer, high-avidity ant

175 injection of donor splenocytes and complete Freund's adjuvant eliminates autoimmunity and permanentl

176 istration of the B9-23 peptide in incomplete Freund's adjuvant enhanced their insulin autoantibody re

177 When WEB2170 was added to OVA in complete Freund's adjuvant, enhanced IgG2a but not IgG1 productio

178 were immunized with IRBP mixed with complete Freund's adjuvant; eyes were enucleated on day 7 after i

179 ), whereas rabbits immunized with PPSV23 and Freund's adjuvant failed to show differences in clinical

180 ith pneumococcal capsular polysaccharide and Freund's adjuvant fails to produce opsonizing antibodies

181 e fragments of target antigens in incomplete Freund's adjuvant has resulted in severe anaphylactic re

182 (Ad5-OVA), and OVA delivered with incomplete Freund's adjuvant (IFA(OVA)).

183 Using an emulsion of incomplete Freund's adjuvant (IFA) as a co-delivery vehicle, it was

184 ccine administered to neonates in incomplete Freund's adjuvant (IFA) induced such cells in reduced nu

185 ase, while animals immunized with incomplete Freund's adjuvant (IFA) remain susceptible.

186 d) mice, immunization with HEL in incomplete Freund's adjuvant (IFA) resulted in Th2-dominated immune

187 -chain peptide 9-23 emulsified in incomplete Freund's adjuvant (IFA) was also potent at preventing on

188 BP KO mice immunized with IRBP in incomplete Freund's adjuvant (IFA), lacking mycobacteria (whereas t

189 Treatment with E2 peptide2 in incomplete Freund's adjuvant (IFA), resulted in higher antibody pro

190 by albumin/AlbiVax than benchmark incomplete Freund's adjuvant (IFA).

191 dministration of S2-16 peptide in incomplete Freund's adjuvant (IFA).

192 370D) (YMDGTMSQV) emulsified with incomplete Freund's adjuvant (IFA).

193 uble antigens requires the use of incomplete Freund's adjuvant (IFA).

194 injection of the same peptide in incomplete Freund's adjuvant (IFA).

195 ntradermal injections of gliadin in complete Freund's adjuvant (immunization) or of soluble gliadin o

196 e subcutaneous route with rHag B in complete Freund's adjuvant, immunized with rHag B and orally infe

197 quent challenge with the peptide in complete Freund's adjuvant in adult life, although this neonatal

198 cord slices from rats injected with complete Freund's adjuvant in one hindpaw and from uninflamed con

199 search for an adjuvant that is comparable to Freund's adjuvant in potency and is safe for use in huma

200 ing thermal hyperalgesia induced by complete Freund's adjuvant in rats (MED = 1 mg/kg, p.o).

201 ing thermal hyperalgesia induced by complete Freund's adjuvant in rats.

202 n A/J mice immunized with myosin in complete Freund's adjuvant in that myosin-specific antibodies and

203 nduced by subcutaneous injection of Complete Freund's Adjuvant in the left hind paw of Sprague-Dawley

204 by 6 wk after a challenge with human GAA and Freund's adjuvant; in contrast, administration of the AA

205 fic IgG responses when immunized in complete Freund's adjuvant, indicating that B7-1 and B7-2 can hav

206 ection and not when administered in complete Freund's adjuvant, indicating that molecular mimicry-ind

207 nization with the same antigen in incomplete Freund's adjuvant induced a strong IgG1 response with on

208 H1 conjugated with keyhole limpet hemocyanin Freund's adjuvant induced humoral and cellular anti-3H1

209 n of transgenic animals with MBP in complete Freund's adjuvant induced IFN-gamma-secreting Th1 cells

210 , and immunization with antigen and complete Freund's adjuvant induced interferon-gamma-secreting, an

211 ice with myocarditogenic peptide in complete Freund's adjuvant induced the infiltration of IL-17A-pro

212 agonist of TRPA1) and reversed CFA (Complete Freund's Adjuvant)-induced inflammation and thermal hype

213 alin-induced spontaneous behaviors, complete Freund's adjuvant-induced heat and mechanical hypersensi

214 ete Freund's adjuvant), intradermal complete Freund's adjuvant-induced hindlimb inflammation 1 and 4

215 Here, we show that in rats with Freund's adjuvant-induced inflammation, the increased do

216 models of SCD and cancer as well as complete Freund's adjuvant-induced pain.

217 s-like immunoreactivity in a rodent complete Freund's adjuvant-induced peripheral inflammatory model

218 (ED50 = 30 micromolkg s.c.) reduced complete Freund's adjuvant-induced thermal hyperalgesia in the ra

219 pain models, we found no change in Complete Freund's adjuvant-induced thermal or mechanical hypersen

220 bovine collagen (CII) emulsified in complete Freund's adjuvant inhibited T helper type 1 differentiat

221 mal hyperalgesia after intraplantar complete Freund's adjuvant injection (ED(50) = 41 mg/kg, i.p.).

222 sed thermal hyperalgesia induced by complete Freund's adjuvant injection and reduced response to acid

223 e phase inflammatory pain following complete Freund's adjuvant injection and the late phase neuropath

224 ically increased within 24 h of the complete Freund's adjuvant injection.

225 mation was produced by injection of complete Freund's adjuvant into one hindpaw in rats, and neurons

226 injection of an inflammatory agent, complete Freund's adjuvant, into the masseter muscle and perfused

227 -inducing chromic gut; and (4) CFA (complete Freund's adjuvant), intradermal complete Freund's adjuva

228 toreceptor retinoid-binding protein/complete Freund's adjuvant (IRBP/CFA) or adoptive transfer of T c

229 dministered parenterally to rabbits and that Freund's adjuvant is a better adjuvant than QS-21.

230 e conserved protein virulence factor PLY and Freund's adjuvant is able to reduce corneal inflammation

231 ipheral inflammation (intraplanatar complete Freund's adjuvant) is substantially diminished in the nu

232 nalysis of allografts from vimentin/complete Freund's adjuvant mice demonstrated increased numbers of

233 d White rabbits were actively immunized with Freund's adjuvant mixed with pneumolysin toxoid (psiPLY)

234 ted antiallodynic efficacy in a rat complete Freund's adjuvant model for inflammatory pain showing im

235 Several agonists were active in the complete Freund's adjuvant model of chronic inflammatory thermal

236 Complete Freund's Adjuvant model of cutaneous pain was used to st

237 in the tail immersion assay, in the complete Freund's adjuvant model of inflammatory pain and in the

238 model of neuropathic pain or in the Complete Freund's adjuvant model of inflammatory pain.

239 mulated as a stable emulsion with incomplete Freund's adjuvant (Montanide ISA 51; Seppic SA, Paris, F

240 dose) or gp100:209-217(210M) plus incomplete Freund's adjuvant (Montanide ISA-51) once per cycle, fol

241 tion with ESO(157-170) mixed with incomplete Freund's adjuvant (Montanide ISA51) in 18 HLA-DP4+ EOC p

242 njection of capsaicin, formalin, or complete Freund's adjuvant more effectively than unconjugated CGR

243 DO11.10) along with OVA peptide and complete Freund's adjuvant, observing a dramatic increase in OVA-

244 livered singly or in combination with either Freund's adjuvant or alum, indicated that augmented bact

245 ith gB, which was coadministered with either Freund's adjuvant or alum.

246 either protein or peptide in the presence of Freund's adjuvant or LPS.

247 cells are seen after injection with complete Freund's adjuvant or malaria infection.

248 PSQQVMTP (nonantigenic region of Sm B/B') in Freund's adjuvant or with no peptide.

249 abbits that were mock immunized with PBS and Freund's adjuvant or with PPSV23 and Freund's adjuvant a

250 Using an inflammatory (complete Freund's adjuvant) or neuropathic (spared nerve injury)

251 s in immunogenic formulations based on alum, Freund's adjuvant, or two different types of liposomes.

252 after i.p. immunization with OVA peptide in Freund's adjuvant (OVA(323-339)/CFA).

253 ed with gp100 melanoma peptide in incomplete Freund's adjuvant (peptide/IFA), which is commonly used

254 We previously reported that vaccination with Freund's adjuvant plus the recombinant N-terminus of the

255 Unilateral hind paw injections of complete Freund's adjuvant produced inflammation, hyperalgesia of

256 f nonhuman primates with E. coli MSP1(42) in Freund's adjuvant protected six of seven Aotus monkeys f

257 train 35000HP (nHgbAI) and administered with Freund's adjuvant provided complete protection against a

258 A in CFA and boosted with PsaA in incomplete Freund's adjuvant (PsaA-Adj).

259 G3 2/4/6/7-VLPs) or SA11 simian rotavirus in Freund's adjuvants, QS-21 (saponin adjuvant), or aluminu

260 rom donor hearts placed in vimentin/complete Freund's adjuvant recipients contained anti-vimentin ant

261 adjuvants, whereas the response to complete Freund's adjuvant remained intact.

262 ming of recipients with beta-gal in complete Freund's adjuvant resulted in an increased frequency of

263 57BL/6 mice with murine vimentin in complete Freund's adjuvant resulted in anti-vimentin antibodies a

264 tion of Aotus monkeys with BVp42 in complete Freund's adjuvant resulted in high antibody titers again

265 Injection of complete Freund's adjuvant resulted in inflammation and swelling

266 with soluble B. malayi antigen and complete Freund's adjuvant resulted in significantly fewer IL-4-p

267 While alum, Freund's adjuvant, Ribi adjuvant system, and TiterMax we

268 h schistosome egg antigens (SEA) in complete Freund's adjuvant (SEA/CFA) correlates with elevated pro

269 sensitized compared with ovalbumin/complete Freund's adjuvant sensitized (p < or = 0.01).

270 tus monkeys immunized with BVp42 in complete Freund's adjuvant showed evidence of protection of prote

271 By adoptive transfer and complete Freund's adjuvant stimulation experiments, we demonstrat

272 WI-1 immunization, given in Freund's adjuvant subcutaneously in two doses 2 weeks ap

273 atory pain was induced by injecting complete Freund's adjuvant subcutaneously into one hind paw of ra

274 of antigen-specific IgG2a than did complete Freund's adjuvant, suggesting an enhanced TH1 response.

275 allenged with antigen emulsified in complete Freund's adjuvant, the overall pattern was similar, exce

276 were preimmunized with the KLH in incomplete Freund's adjuvant to induce a population of Th2 memory c

277 albumin with alum or ovalbumin with complete Freund's adjuvant to induce T helper type 2 or T helper

278 eceptor retinoid-binding protein in complete Freund's adjuvant to test their efficacy in suppressing

279 njecting mycobacterium cell wall in complete Freund's adjuvant using standard techniques.

280 This preparation, mixed with Freund's adjuvant using vortexing or sonication, was use

281 Protective formulation required Freund's adjuvant; vaccination with yP30P2MSP1(19) in si

282 mechanical hyperalgesia induced by complete Freund's adjuvant was accompanied by C5a upregulation an

283 ted with intraperitoneal antigen in complete Freund's adjuvant was examined.

284 sequent response to immunization with OVA in Freund's adjuvant was monitored.

285 pes when injected subcutaneously in complete Freund's adjuvant was significantly enhanced if administ

286 tion from infection in the rabbit model when Freund's adjuvant was used.

287 PC prepared with PEC induced with incomplete Freund's adjuvant were ineffective.

288 m rabbits actively immunized with PPSV23 and Freund's adjuvant were nonopsonizing.

289 esence or absence of LT(R192G) or incomplete Freund's adjuvant were not protected against lethal chal

290 eas of the rabbits immunized with psiPLY and Freund's adjuvant were significantly lower than scores o

291 mice and mice immunized with saline-complete Freund's adjuvant were used as controls.

292 earlier with proteolipid protein in complete Freund's adjuvant, were injected with 3 x 10(6) cells fr

293 inflammatory stimuli, formalin and complete Freund's adjuvant, were reduced or abolished in AC1&8 DK

294 nized and boosted with a GABHS homogenate in Freund's adjuvant, whereas controls received Freund's ad

295 se models require immunization with complete Freund's adjuvant, whereas others suggest that a decreas

296 ore potent than that obtained using Complete Freund's Adjuvant with gp100, whereas no response was ob

297 nge containing guinea pig myelin in complete Freund's adjuvant with or without KLH.

298 in saline or intraperitoneally in incomplete Freund's adjuvant, with large quantities of the immunodo

299 rimmune sera of rabbits immunized with PA in Freund's adjuvant, with peak neutralization titers 23-,

300 o the induction of arthritis with incomplete Freund's adjuvant, with similar effects in arthritis ind